Personalis, Inc. (PSNL)
16.28
+0.11
(+0.68%)
USD |
NASDAQ |
Oct 02, 16:00
16.29
+0.01
(+0.06%)
After-Hours: 20:00
Personalis Max Drawdown (5Y) : 98.18% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 98.18% |
| August 31, 2026 | 98.18% |
| July 31, 2026 | 98.18% |
| June 30, 2026 | 98.18% |
| May 31, 2026 | 98.18% |
| April 30, 2026 | 98.18% |
| March 31, 2026 | 98.18% |
| February 28, 2026 | 98.18% |
| January 31, 2026 | 98.18% |
| December 31, 2025 | 98.18% |
| November 30, 2025 | 98.18% |
| October 31, 2025 | 98.18% |
| September 30, 2025 | 98.18% |
| August 31, 2025 | 98.18% |
| July 31, 2025 | 98.18% |
| June 30, 2025 | 98.18% |
| May 31, 2025 | 98.18% |
| April 30, 2025 | 98.18% |
| March 31, 2025 | 98.18% |
| February 28, 2025 | 98.18% |
| January 31, 2025 | 98.18% |
| December 31, 2024 | 98.18% |
| November 30, 2024 | 98.18% |
| October 31, 2024 | 98.18% |
| September 30, 2024 | 98.18% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.18% |
| July 31, 2024 | 98.18% |
| June 30, 2024 | 98.18% |
| May 31, 2024 | 98.18% |
| April 30, 2024 | 98.18% |
| March 31, 2024 | 98.18% |
| February 29, 2024 | 98.18% |
| January 31, 2024 | 98.18% |
| December 31, 2023 | 98.18% |
| November 30, 2023 | 98.18% |
| October 31, 2023 | 98.18% |
| September 30, 2023 | 97.67% |
| August 31, 2023 | 97.06% |
| July 31, 2023 | 96.51% |
| June 30, 2023 | 96.51% |
| May 31, 2023 | 96.51% |
| April 30, 2023 | 96.51% |
| March 31, 2023 | 96.51% |
| February 28, 2023 | 96.51% |
| January 31, 2023 | 96.51% |
| December 31, 2022 | 96.51% |
| November 30, 2022 | 95.55% |
| October 31, 2022 | 95.43% |
| September 30, 2022 | 94.34% |
| August 31, 2022 | 93.63% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Tempus AI, Inc. | -- |
| 10X Genomics, Inc. | 96.47% |
| Alamar Biosciences, Inc. (California) | -- |
| Adaptive Biotechnologies Corp. | 96.55% |
| Champions Oncology, Inc. | 78.53% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -30.24 |
| Beta (5Y) | 2.315 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 118.0% |
| Historical Sharpe Ratio (5Y) | -0.0599 |
| Historical Sortino (5Y) | -0.2033 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.30% |